Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A McCann

Showing results (201-210 of 247) with videos related to

Pageof 25
Sort By:
BMJ (Clinical Research Ed.)|December 17, 2013
The Brady Bunch? New evidence for nominative determinism in patients' health: retrospective, population based cohort studyJohn J Keaney, John D Groarke, Zita Galvin, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 28, 2025
Monte Carlo study of the eye lens exposure of medical staff administering Sc-47 and Cu-67 labelled radiopharmaceuticalsP Ferrari, F Becker, J Dabin, et al.
Journal of Animal Science|November 7, 2003
Use of nonergot alkaloid-producing endophytes for alleviating tall fescue toxicosis in stocker cattleJ A Parish, M A McCann, R H Watson, et al.
Gynecologic Oncology|July 20, 2014
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.
Cancer Research|December 20, 1999
Frequent loss of imprinting of PEG1/MEST in invasive breast cancerI S Pedersen, P A Dervan, D Broderick, et al.
The American Journal of Cardiology|March 12, 1999
Histopathologic changes in asymptomatic relatives of patients with idiopathic dilated cardiomyopathyC J McKenna, D D Sugrue, H M Kwon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Gynecologic Oncology|November 10, 2012
The impact of close surgical margins after radical hysterectomy for early-stage cervical cancerGeorgia A McCann, Susanne K Taege, Christina E Boutsicaris, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Gynecologic Oncology|January 30, 2013
Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage diseaseGeorgia A McCann, Christina E Boutsicaris, Megan M Preston, et al.
Pageof 25

Showing results (201-210 of 247) with videos related to

Sort By:
Pageof 25
BMJ (Clinical Research Ed.)|December 17, 2013
The Brady Bunch? New evidence for nominative determinism in patients' health: retrospective, population based cohort studyJohn J Keaney, John D Groarke, Zita Galvin, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|August 28, 2025
Monte Carlo study of the eye lens exposure of medical staff administering Sc-47 and Cu-67 labelled radiopharmaceuticalsP Ferrari, F Becker, J Dabin, et al.
Journal of Animal Science|November 7, 2003
Use of nonergot alkaloid-producing endophytes for alleviating tall fescue toxicosis in stocker cattleJ A Parish, M A McCann, R H Watson, et al.
Gynecologic Oncology|July 20, 2014
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.
Cancer Research|December 20, 1999
Frequent loss of imprinting of PEG1/MEST in invasive breast cancerI S Pedersen, P A Dervan, D Broderick, et al.
The American Journal of Cardiology|March 12, 1999
Histopathologic changes in asymptomatic relatives of patients with idiopathic dilated cardiomyopathyC J McKenna, D D Sugrue, H M Kwon, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Gynecologic Oncology|November 10, 2012
The impact of close surgical margins after radical hysterectomy for early-stage cervical cancerGeorgia A McCann, Susanne K Taege, Christina E Boutsicaris, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Gynecologic Oncology|January 30, 2013
Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage diseaseGeorgia A McCann, Christina E Boutsicaris, Megan M Preston, et al.
Pageof 25